The prognostic impact of tumor mutational burden (tmb) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (nsclc): a systematic review and meta-analysis of randomized controlled trials

HIGHLIGHTS

• who: A. Galvano from the Department of Surgical, Oncological and Oral Sciences, University of Palermo, PalermoBiomedicine and Clinical Neurosciences, University of Palermo, Palermo, Italy have published the research: The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials, in the Journal: (JOURNAL) of 30/09/2020
• what: Based on the most updated clinical evidence, the purpose of this meta-analysis was to compare objective response rate (ORR), PFS, and OS among . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.